Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Arai (Sakai, Japan), S. Shintani (Sakai, Japan), C. Sugimoto (Sakai, Japan), N. Takeuchi (Sakai, Japan), T. Kagawa (Sakai, Japan), Y. Inoue (Sakai, Japan), K. Tachibana (Sakai, Japan), M. Akira (Sakai, Japan), Y. Inoue (Sakai, Japan). Severity before or at the onset of acute exacerbation (AE) can predict the long-term and short-term survival of AE in idiopathic interstitial pneumonias (IIPs)?. 811

Member's Comments

No comment yet.

Related content which might interest you: Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study Source: Eur Respir J 2012; 40: 101-109 Year: 2012 Different characteristics and outcomes of acute exacerbation: comparison between interstitial pneumonia with autoimmune features and lone idiopathic interstitial pneumonia. Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias Year: 2018 Does the condition of chronic obstructive pumonary disease (COPD) have a prognostic benefit in patients with community-acquired pneumonia (CAP)? Source: Eur Respir J 2003; 22: Suppl. 45, 338s Year: 2003 Survival after respiratory hospitalization in patients with idiopathic chronic fibrosing interstitial pneumonia Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias? Year: 2018 Characteristics and outcomes of hospitalizations for acute exacerbation of chronic obstructive pulmonary disease (AECOPD) Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease Year: 2012 Can we predict the outcomes of treatment of patients with severe exacerbation of chronic obstructive pulmonary disease (COPD)? Source: Eur Respir J 2001; 18: Suppl. 33, 241s Year: 2001 Severity assessment in acute exacerbations of COPD Source: Annual Congress 2005 - Infection and acute exacerbation of COPD: what do we know? Year: 2005 Co-morbidity and hospitalization rate in patients (pts) with acute exacerbation (AE) of COPD Source: International Congress 2015 – Different data in COPD Year: 2015 Patient’s knowledge about risk factors for acute exacerbation( AE ) of chronic obstructive pulmonary disease( COPD ) Source: Eur Respir J 2004; 24: Suppl. 48, 514s Year: 2004 Acute exacerbation of COPD (AECOPD) during pulmonary rehabilitation (PR): impact on outcomes and short-term prediction of risk. Source: International Congress 2017 – Latest insights into chronic care Year: 2017 In hospitalized COPD exacerbation (COPDE) patients a 30-day readmission is associated with a progressive increased risk of mortality Source: International Congress 2015 – COPD: interesting notes Year: 2015 7 Years survival of patients with acute exacerbations of chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 211s Year: 2001 Quantifying risk of mortality in idiopathic interstitial pneumonia (IIP) Source: Eur Respir J 2001; 18: Suppl. 33, 149s Year: 2001 Surfactant protein D (SPD) like marker of effectiveness in patients (pts) with acute exacerbations (AE) of COPD ofphosphatidylcholine treatment outcomes Source: International Congress 2015 – Different data in COPD Year: 2015 Disease severity for enrollment criteria of patients with idiopathic pulmonary fibrosis (IPF) in clinical trial: evaluation of time to first episode of acute exacerbation (TTA) Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis Year: 2009 The difference between surfactant protein D (SPD) and C-reactive protein (CRP) levels in patients (pts) with chronic obstructive pulmonary disease acute exacerbations (AE COPD) and community acquired pneumonia (CAP) Source: International Congress 2014 – Clinical presentations Year: 2014 Outcome of patients following hospitalization with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) , with and without cardiovascular risk factors Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Severity and outcomes of hospitalised community-acquired pneumonia in COPD patients Source: Eur Respir J 2012; 39: 855-861 Year: 2012 Comparison of patient-reported outcomes (PROs) during acute exacerbation of chronic obstructive pulmonary disease Source: International Congress 2016 – Monitoring airway diseases with clinical tools Year: 2016 Mucociliary clearance (MCC) disorders in patient with acute bronchitis (AB) and acute exacerbation (AE) of COPD and ways of it correction Source: Annual Congress 2009 - Drug effects in COPD Year: 2009